FOLH1 and posterior cortical atrophy: Here, we conducted a series of preclinical evaluations to fully characterize the biodistribution and to evaluate the therapeutic efficacy of 177Lu-rhPSMA-10.1 in 2 PSMA-expressing PCa models.